Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

706
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
706
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

540
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
540
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

385
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
385
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.3K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

3.9K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.9K
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

2.8K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epileptic-Dyskinetic Encephalopathy in Snijders Blok-Campeau Syndrome: Expanding the Phenotypic Spectrum.

Movement disorders clinical practice·2026
Same author

Atypical Phenotype of Marinesco-Sjögren Syndrome with Predominant Myopathy due to a Novel SIL1 Variant.

Annals of Indian Academy of Neurology·2026
Same author

Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR-PSP).

Movement disorders clinical practice·2026
Same author

Correction: Deep brain stimulation for Parkinson's disease in India: an expert consensus on availability, affordability, and eligibility by the Parkinson's research alliance India (PRAI).

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Expanding the Phenotype: Myoclonus-Dystonia as a Novel Manifestation of 47 XXX Syndrome.

Journal of movement disorders·2026
Same author

Barriers and facilitators to advance care planning implementation for patients with neurodegenerative diseases among Indian physicians: a mixed-methods analysis.

BMC health services research·2026

Related Experiment Video

Updated: Oct 22, 2025

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
10:23

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy

Published on: June 23, 2023

2.3K

Myoclonus- A Review.

Mitesh Chandarana1, Udit Saraf1, K P Divya1

  • 1Comprehensive Care Centre for Movement Disorders, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.

Annals of Indian Academy of Neurology
|August 27, 2021
PubMed
Summary

Myoclonus, a hyperkinetic movement disorder, involves involuntary jerks. Effective management requires understanding its diverse causes and classifications, prioritizing underlying etiology treatment.

Keywords:
Classificationelectrophysiologyetiologymyoclonustreatment

More Related Videos

Corticospinal Excitability Modulation During Action Observation
12:33

Corticospinal Excitability Modulation During Action Observation

Published on: December 31, 2013

9.1K
The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders
10:08

The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders

Published on: August 25, 2022

3.1K

Related Experiment Videos

Last Updated: Oct 22, 2025

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
10:23

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy

Published on: June 23, 2023

2.3K
Corticospinal Excitability Modulation During Action Observation
12:33

Corticospinal Excitability Modulation During Action Observation

Published on: December 31, 2013

9.1K
The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders
10:08

The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders

Published on: August 25, 2022

3.1K

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • Myoclonus is a hyperkinetic movement disorder defined by sudden, brief, involuntary muscle jerks.
  • It is categorized as positive (muscle contraction) or negative (cessation of contraction).
  • Classification can be based on distribution, activity, neurophysiology, and etiology.

Purpose of the Study:

  • To review the etiology, classification, clinical approach, and management of myoclonus.
  • To highlight the importance of neurophysiological classification for guiding therapeutic strategies.
  • To emphasize the need for thorough evaluation and treatment of underlying causes.

Main Methods:

  • Review of existing literature on myoclonus.
  • Analysis of classification systems, including neurophysiological approaches.
  • Discussion of diagnostic evaluation, encompassing history, physical examination, and laboratory/neurophysiological studies.
  • Examination of treatment strategies, including symptomatic and etiological approaches.

Main Results:

  • Myoclonus classification aids in understanding and managing the disorder.
  • Electrophysiological tests are crucial for neurophysiological classification and treatment guidance.
  • Identifying and treating the underlying cause is paramount, though symptomatic treatment is often necessary.
  • Symptomatic treatment can be challenging, frequently requiring combination therapy.

Conclusions:

  • A comprehensive approach integrating etiology, classification, and clinical evaluation is essential for effective myoclonus management.
  • Neurophysiological classification provides valuable insights for therapeutic decision-making.
  • While symptomatic relief is important, addressing the root cause offers the best long-term outcome for myoclonus patients.